Published in Rheumatol Int on January 01, 1993
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis (2007) 4.05
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis (2010) 3.90
The paradigm of IL-6: from basic science to medicine. Arthritis Res (2002) 2.34
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Ann Rheum Dis (2014) 1.80
Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis (2000) 1.56
Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Devel Ther (2010) 1.38
Tocilizumab. Nat Rev Drug Discov (2009) 1.36
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) (2009) 1.24
Activation of synovial fibroblasts in rheumatoid arthritis. Ann Rheum Dis (1995) 1.03
Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Devel Ther (2014) 0.97
The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis (2010) 0.92
Expression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritis. Arthritis Res Ther (2005) 0.91
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int (2010) 0.89
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis. Ther Clin Risk Manag (2010) 0.86
Interleukin-6 levels in synovial fluids of patients with rheumatoid arthritis correlated with the infiltration of inflammatory cells in synovial membrane. Rheumatol Int (2006) 0.85
Early intervention in the treatment of rheumatoid arthritis: focus on tocilizumab. Ther Clin Risk Manag (2013) 0.81
Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol (2017) 0.80
Eleutheroside E ameliorates arthritis severity in collagen-induced arthritis mice model by suppressing inflammatory cytokine release. Inflammation (2014) 0.79
The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis. Clin Exp Immunol (2017) 0.79
Efficacy of tocilizumab on MRI-determined bone oedema in rheumatoid arthritis. Clin Rheumatol (2015) 0.78
Reduction of interleukin-6 expression in human synoviocytes and rheumatoid arthritis rat joints by linear polarized near infrared light (Superlizer) irradiation. Laser Ther (2011) 0.76
Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis. Front Immunol (2017) 0.75
Interrelationship between synovial fluid interleukin (IL)-6, IL-1 beta and disease activity indices in rheumatoid arthritis. Rheumatol Int (1994) 0.75
Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis. J Exp Orthop (2014) 0.75
2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75
A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J Exp Med (1986) 3.92
Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet (1998) 2.63
CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51
Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur J Immunol (1987) 2.45
Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology (2006) 2.24
Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen. Proc Natl Acad Sci U S A (1986) 2.10
Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis (2004) 2.09
Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis (1999) 2.06
Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum (1997) 1.89
Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen. Infect Immun (1992) 1.68
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta Psychiatr Scand (2005) 1.67
The product of the Herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells. J Biol Chem (1995) 1.65
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells. Arthritis Res (2000) 1.62
Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol (1996) 1.61
Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J Leukoc Biol (1996) 1.57
Hypertension as a risk factor for cerebral injury during cardiopulmonary bypass. Protein S100B and transcranial Doppler findings. Anaesthesia (2001) 1.47
Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum (1991) 1.45
Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur J Immunol (1987) 1.43
Deficits in fronto-posterior interactions point to inefficient resource allocation in schizophrenia. Acta Psychiatr Scand (2010) 1.42
Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin. Infect Immun (1993) 1.41
Ventricular fibrillation due to hypocalcemia after parathyroidectomy with autotransplantation of parathyroid tissue in a dialysis patient. Nephron (1995) 1.38
Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem (1992) 1.38
[The effect of different anesthetic procedures on hormone levels in women. Studies during an in vitro fertilization-embryo transfer (IVF-ET) program]. Anaesthesist (1994) 1.38
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation (1994) 1.27
CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis. Clin Pharmacol Ther (2009) 1.25
Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur J Immunol (1987) 1.23
Mass changes of inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate during cell cycle progression in rat thymocytes. J Biol Chem (1993) 1.21
Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry (2004) 1.16
Intracellular Ca2+ pools in Jurkat T-lymphocytes. Biochem J (1993) 1.15
A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods (1994) 1.14
Systemic macrophage activation in locally-induced experimental arthritis. J Autoimmun (2001) 1.13
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci (1999) 1.12
First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia. Int J Tuberc Lung Dis (2012) 1.11
Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.10
Soil diversity and hydration as observed by ChemCam at Gale crater, Mars. Science (2013) 1.10
Immortalization of human T cell clones by Herpesvirus saimiri. Signal transduction analysis reveals functional CD3, CD4, and IL-2 receptors. J Immunol (1993) 1.10
Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol (1993) 1.08
T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? Biochim Biophys Acta (1997) 1.06
Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens. Blood (1986) 1.06
Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol (1998) 1.05
Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis (2000) 1.05
Interaction of enteropathogenic Yersinia enterocolitica with complex basement membranes and the extracellular matrix proteins collagen type IV, laminin-1 and -2, and nidogen/entactin. J Biol Chem (1994) 1.03
Activation of synovial fibroblasts in rheumatoid arthritis. Ann Rheum Dis (1995) 1.03
Depletion of gamma/delta T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis. Arthritis Rheum (1996) 1.02
Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J (2005) 1.02
Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol (1999) 1.01
Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur J Immunol (1990) 1.01
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol (2004) 1.01
Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry (1995) 1.00
Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes. Arthritis Rheum (1995) 0.99
Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol (1990) 0.98
Primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr (1988) 0.98
Characterization of cyclic adenosine diphosphate-ribose-induced Ca2+ release in T lymphocyte cell lines. J Immunol (1995) 0.98
Cross-linking of CD4 and CD8 with the T-cell receptor complex: quaternary complex formation and T-cell repertoire selection. Immunol Today (1988) 0.97
D-myo-inositol 1,3,4,5-tetrakisphosphate releases Ca2+ from crude microsomes and enriched vesicular plasma membranes, but not from intracellular stores of permeabilized T-lymphocytes and monocytes. Biochem J (1992) 0.96
Grafting of fibroblasts isolated from the synovial membrane of rheumatoid arthritis (RA) patients induces chronic arthritis in SCID mice-A novel model for studying the arthritogenic role of RA fibroblasts in vivo. J Autoimmun (2000) 0.96
Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol (1994) 0.96
Keratan sulfate proteoglycan in rabbit compact bone is bone sialoprotein II. J Biol Chem (1987) 0.94
Distribution of TNF-alpha, TNF-R55 and TNF-R75 in the rheumatoid synovial membrane: TNF receptors are localized preferentially in the lining layer; TNF-alpha is distributed mainly in the vicinity of TNF receptors in the deeper layers. Scand J Immunol (1999) 0.94
High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis. Clin Rheumatol (2000) 0.93
Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy. Infect Immun (1986) 0.93
Induction of flare-up reactions in rat antigen-induced arthritis. J Autoimmun (1995) 0.93
Cytokine gene activation in synovial membrane, regional lymph nodes, and spleen during the course of rat adjuvant arthritis. Cell Immunol (1999) 0.93
Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis. Clin Immunol Immunopathol (1991) 0.92
Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol (1992) 0.92
T cell reactivity in neonates from an East and a West German city--results of the LISA study. Allergy (2002) 0.91
Pregnancy in a 31 in. (77.5 cm.) dwarf. Br Med J (1965) 0.91
Peri/intraventricular haemorrhage: a cranial ultrasound study on 5286 neonates. Eur J Obstet Gynecol Reprod Biol (1997) 0.91
Central giant cell granuloma of the mandible. J Oral Maxillofac Surg (1983) 0.90
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann Rheum Dis (2004) 0.90
Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins. Infect Immun (1993) 0.90
[Procedures according to data protection laws for coupling primary and secondary data in a cohort study: the lidA study]. Gesundheitswesen (2012) 0.90
Xenon expenditure and nitrogen accumulation in closed-circuit anaesthesia. Anaesthesia (2001) 0.90
The second messenger binding site of inositol 1,4,5-trisphosphate 3-kinase is centered in the catalytic domain and related to the inositol trisphosphate receptor site. J Biol Chem (2000) 0.89
Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum (1994) 0.89
Emotional and behavioural problems in children and adolescents with primary headache. Cephalalgia (2003) 0.89
Immunoglobulin determinants on the surface of lymphoid cells of carps. Eur J Immunol (1975) 0.89
The suppressive effect of an antibody to the alpha beta cell receptor in rat adjuvant arthritis: studies on optimal treatment protocols. Autoimmunity (1990) 0.89
The pill and the pituitary. Br Med J (1972) 0.88
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest (1990) 0.88
Activation of human T lymphocytes: differential effects of CD3- and CD8-mediated signals. Proc Natl Acad Sci U S A (1988) 0.88
Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis). J Autoimmun (1999) 0.88
Effects of low dose radiation therapy on adjuvant induced arthritis in rats. Int J Radiat Biol (2000) 0.88
Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies. Eur J Nucl Med (1990) 0.88
Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagen. Arthritis Rheum (1995) 0.87
Gelatin-based haemostyptic Spongostan as a possible three-dimensional scaffold for a chondrocyte matrix?: an experimental study with bovine chondrocytes. J Bone Joint Surg Br (2009) 0.87
Karyotypic characterization of human T-cell lines immortalized by Herpesvirus saimiri. Int J Cancer (1994) 0.87
A cross-reacting human idiotype (B17) associated with antibodies to N-acetyl-D-glucosamine. Specificity, immunoglobulin class association, and distribution in the population. Eur J Immunol (1983) 0.87
Kinetics of rhodopsin bleaching in the isolated human retina. J Physiol (1973) 0.87
On the significance of magnesium in extreme physical stress. Cardiovasc Drugs Ther (1998) 0.86
Young chronic patients and substance abuse. Hosp Community Psychiatry (1989) 0.86